Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

DONCEPT F.C. TABLET 5MG

Approval Number

SIN15086P

Drug Name

DONCEPT F.C. TABLET 5MG

Product Name

DONCEPT F.C. TABLET 5MG

Approval Date

September 13, 2016

Registrant

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Licence Holder

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Regulatory Information

Registrant

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Licence Holder

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

TABLET, FILM COATED

Route of Administration

ORAL

Medical Information

ATC Code

N06DA02

ATC Item Name

donepezil

Manufacturer Information

Pharmaceutical Manufacturer

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Manufacturers

Actavis Ltd.

Active Ingredients

Ingredient Name

Donepezil Hydrochloride Monohydrate eqv. Donepezil Hydrochloride

Strength

5mg

Drug MonographDonepezil

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy